Tango Therapeutics
Develops precision cancer medicines using synthetic lethality principles.
Company facts
- Founded
- 2017
- Employees
- 155
- Headquarters
- United States
- Type
- Public
- Listed
- Nasdaq Capital Market: TNGX
- Subsidiaries
- Tango Therapeutics Sub, Inc., Tango Securities Corporation